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Handling variability and incompleteness of biological data by
ﬂexible nets: a case study for Wilson disease
Jorge Júlvez 1,2,3, Duygu Dikicioglu1,2,4 and Stephen G. Oliver 1,2
Mathematical models that combine predictive accuracy with explanatory power are central to the progress of systems and
synthetic biology, but the heterogeneity and incompleteness of biological data impede our ability to construct such models.
Furthermore, the robustness displayed by many biological systems means that they have the ﬂexibility to operate under a range of
physiological conditions and this is difﬁcult for many modeling formalisms to handle. Flexible nets (FNs) address these challenges
and represent a paradigm shift in model-based analysis of biological systems. FNs can: (i) handle uncertainties, ranges and missing
information in concentrations, stoichiometry, network topology, and transition rates without having to resort to statistical
approaches; (ii) accommodate different types of data in a uniﬁed model that integrates various cellular mechanisms; and (iii) be
employed for system optimization and model predictive control. We present FNs and illustrate their capabilities by modeling a well-
established system, the dynamics of glucose consumption by a microbial population. We further demonstrate the ability of FNs to
take control actions in response to genetic or metabolic perturbations. Having bench-marked the system, we then construct the
ﬁrst quantitative model for Wilson disease—a rare genetic disorder that impairs copper utilization in the liver. We used this model
to investigate the feasibility of using vitamin E supplementation therapy for symptomatic improvement. Our results indicate that
hepatocytic inﬂammation caused by copper accumulation was not aggravated by limitations on endogenous antioxidant supplies,
which means that treating patients with antioxidants is unlikely to be effective.
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INTRODUCTION
In silico mathematical models are valuable tools in biological
research since they can not only deepen our understanding of
biological systems, especially when data availability is a limiting
factor, but also reduce the time and costs associated with
experiments through predicting their outcomes. These goals can
only be achieved if suitable models and methods to facilitate the
design, analysis, and optimization of biological systems are
available. Model construction relies on the existence of formalisms
that determine how models can be built. Computational
biomodeling has always borrowed modeling formalisms from
other disciplines to enable model construction and analysis. Some
of the most widely used formalisms in biology include, but are not
limited to, Boolean networks,1–3 Bayesian networks,4,5 cellular
automata,6,7 constraint-based models,8,9 ordinary differential
equations (ODEs),10–12 Petri nets13–16 and process algebras.17–19
Although these formalisms have been used in biology and have
achieved various degrees of success, they do not address all of the
difﬁculties presented by biological systems.
The quantity and quality of available biological data present
serious challenges for the construction of models for biological
systems. Despite the so-called “avalanche” of biological data,
many data sets are necessarily incomplete. Moreover, there is a
shortage of particular classes of data, e.g., the biochemical
composition of different cell types, the kinetic constants of
enzymes, or the structure of rate equations. Furthermore, models
must be able to seamlessly accommodate, at various levels,
heterogeneous data related to network topology, stoichiometry,
rates of reactions, and the regulation of biological events.
Conversely, models can also suffer from the availability of too
much data since some biological systems have been investigated
repeatedly, with only slight modiﬁcations, generating a range of
allowable values that describe essentially similar situations. In
addition, if the number of available data sets is not sufﬁciently
large to permit the application of probabilistic approaches, models
often suffer from either a form of averaging, which eliminates
variability, or from the cherry-picking of data, which can introduce
bias into the model’s predictions.
Here, we present a novel framework, which we call Flexible Nets
(FNs), that speciﬁcally targets the modeling and optimization
challenges presented by a wide range of biological systems. FNs
can easily integrate heterogeneous data into a single model, and
can cope with missing or varying information related to
concentrations, stoichiometry, network topology, rates of reac-
tions, and regulation of biological systems. Of the most popular
modeling approaches used in systems biology, only constraint-
based models can handle uncertainties in the ﬂows of reactions.
However, such models cannot accommodate concentrations, and
their analysis is usually limited to the steady state. In contrast to
constraint-based models, ODEs are deterministic descriptions of
the system dynamics that can provide a precise time trajectory of
the system. However, ODEs cannot account for the different
system trajectories that arise as a result of uncertain parameters,
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moreover, the control of non-linear ODEs is a challenging
problem. A major advantage of FNs with respect to these
formalisms lies in its ability to track the evolution of concentra-
tions in time-course analyses while handling uncertain kinetic and
stoichiometric parameters. Moreover, the guarded FNs introduced
here are an appealing alternative to control non-linear systems by
considering a piecewise linear approximation of the system
dynamics.
While FNs have been inspired by Petri nets, these two
formalisms differ in a number of basic aspects. From a structural
perspective, Petri nets are bipartite directed graphs whose nodes
are places and transitions. In contrast, FNs consist of two nets: the
event net and the intensity net. Each of these nets is a tripartite
graph. The nodes of the event net are places, transitions, and
event handlers; those of the intensity net are places, transitions,
and intensity handlers. These nodes are connected both by
directed and undirected edges (in the following, directed edges
will be referred as “arcs”, and undirected edges as “edges”). The
event net is used to model the stoichiometric relationships
between reactants and products. For instance, an event net can be
used to represent metabolic pathways by representing graphically
the amounts of metabolites that are consumed and produced by
the reactions involved in the pathways. The event net does not
specify any rates for the modeled reactions. Such rates are
expressed graphically by an intensity net that is connected to the
event net. For instance, the reaction rates of the mentioned
metabolic pathways can be speciﬁed by means of an intensity net.
Each handler is associated with a set of inequalities that
establishes the stoichiometric relationships in the event net, and
the speed of reactions in the intensity net. Such inequalities can
be used to model system uncertainties. For example, by
associating inequalities with event handlers, different states are
possible in FNs after the occurrence of an event (in contrast to
Petri nets where the resulting state after the ﬁring of a transition is
deterministic). The association of inequalities with intensity
handlers enables a range of reaction rates to be assigned to a
given state. Moreover, the addition of guards to an intensity net
offers the possibility of modeling the complex and non-linear
dynamics of biological systems. All the potential evolutions of an
FN arising from the existing uncertainties are accounted for by
state equations that contain matrix inequalities.
In addition to the FNs modeling formalism, we have also
designed the relevant methods to monitor the evolution of FNs
over time. As FNs can handle initial concentrations, stoichiometry,
reaction rates, and the regulation of reactions as variables, it is
straightforward to derive methods to control and optimize
biological processes. Note that FNs represent an abstract
formalism and, as such, can be used straightforwardly to model
dynamical systems in a wide range of different application
domains, e.g., manufacturing, logistics, computer networks, trafﬁc
systems, etc. Hence their applicability goes far beyond biological
systems (see section FNs for different interpretations of a net that
originally modeled a biological system).
We demonstrate the capabilities of FNs using a widely studied
biological process as a test object: the uptake of glucose and its
subsequent utilization in yeast, which we call glucose consump-
tion hereafter. Having bench-marked the methodology against
this well-studied system, we then constructed the ﬁrst computable
model for Wilson disease. This model can account for the range of
healthy or sick states documented, and can also cope with the
missing information on the mechanistic details of the disease. The
predictions made by analyzing this model have allowed us to
investigate the utility of employing exogenous antioxidant
supplements to alleviate the inﬂammatory response in the
hepatocytes that occurs during copper accumulation. The model
also suggests an alternative way to monitor the impact of a
therapy on the level of copper stores in the liver without having to
resort to invasive techniques, such as a liver biopsy.
RESULTS
FNs overview
A biological system can be described by its “state”, which
represents the quantity of each of the species considered in the
system at a given point in time, and by a set of “processes” (or
events) specifying how the state changes over time. While the
state refers to tangible components, e.g., numbers or concentra-
tion of molecules of each species, processes refer to any reaction,
transformation, or translocation that produces a state change. The
state of an FN can be graphically depicted by “places” and the
processes by “transitions” (see Fig. 1a for an overview of the
graphical representation and semantics of the net elements). FNs
provide explicit and formal means to model the following two
sorts of relationships between states and processes: (a) the
processes determine how the state changes; (b) the state
determines the rate at which the processes are carried out. Such
relationships are established by sets of linear inequalities
associated with a net element, called “handler”, that connects
places and transitions. Linear inequalities make it easy for the
practitioner to introduce uncertainties into the model. Thus, an FN
consists of two subnets: an event net and an intensity net. The
event net models how the processes determine the changes in
the state; the intensity net models how the state determines the
rates of the processes.
Event net
In the following, the FN in Fig. 1b is used to introduce the basic
features and modeling capabilities of FNs. Consider a simple
biological system consisting of two reactions R1 : A→ B and R2 : C
→ D + E. The stoichiometry of these reactions is modeled by the
“event net” (see net elements in green). In the FN, each type of
molecule (A, B, C, D, and E) is associated with a “place” which is
depicted as a circle. The amount (number of molecules or
concentration) of each type of molecule is called a “marking”. The
marking of a given place p is denoted m[p] (the initial marking of p
is denoted m0[p]). The marking of a place can be written inside the
place, e.g., m[A] = 8 in Fig. 1b. The marking of a place p is also
known as the number of tokens in p. FNs can accommodate
uncertain initial markings by means of inequalities, e.g., one can
specify that the initial marking of C can be any value between 10
and 20 by associating the inequality 10≤m0[C]≤ 20 with place C.
Similar to the way places model molecules, “transitions”, which
are depicted as rectangles (see R1 and R2 in Fig. 1b), are used to
model reactions. In FNs, the number of tokens consumed and
produced by the occurrence of a reaction is determined by a net
element called “event handler”, which is depicted as a dot (see v1
and v2 in Fig. 1b). Event handlers are connected to transitions by
edges which are used to specify that the occurrence of a reaction
will be used by the event handler to change the marking of the
places involved in the reaction. Such places are connected to the
event handlers by directed arcs. An arc from a place to an event
handler means that the place is a reactant, i.e., its number of
tokens will decrease when the reaction happens. Similarly, an arc
from an event handler to a place means that the place is a
product, i.e., its number of tokens will increase when the reaction
happens. Each edge and arc is labeled to facilitate its identiﬁcation
(to avoid confusion, all the arcs and edges connected to a given
handler must have different labels). The actual number of tokens
consumed and produced by the occurrence of a reaction is
derived from the set of inequalities that is associated with each
event handler and that makes use of the labels of the arcs and
edges connected to them.
For instance, the labels a, b and r of the arcs and edge
connected to event handler v1 denote the number of tokens
consumed from A, the number of tokens produced in B, and the
number of occurrences of reaction R1 respectively. Assume that
the equations a = b = r are associated with v1. Such equations
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imply that the number of tokens consumed from A is equal to the
number of tokens produced in B, and equal to the number of
occurrences of R1. It follows that a single occurrence of reaction
R1, i.e., r = 1, entails a = b = 1, i.e., it consumes one token from A
and produces one token in B. In other words, the labels of arcs and
edges are used as variables in the equations to specify the
stoichiometric relations. Uncertain stoichiometric relations can
easily be captured by inequalities. For instance, the association of
a = r; 95r≤ b≤ 105r with v1 implies that a single occurrence of R1
consumes one token from A, and the number of tokens produced
in B is selected nondeterministically in the interval [95,105]. Such a
set of inequalities could be useful to model the decomposition of
a large complex into an uncertain number of smaller components.
As another example, the association of r = c = d; 12r≤ e≤ 14r with
v2 would mean that each occurrence of reaction R2 consumes a
token from C, produces a token in D and produces an uncertain
number of tokens in the interval [12,14] in E. See Fig. 2a, b for
other modeling capabilities of event nets.
Intensity net
The “event net”, introduced above, models exclusively stoichio-
metric relationships. In order to model the system dynamics, i.e.,
the rate of the reactions represented by the transitions, the
“intensity net” is introduced (see net elements in blue in Fig. 1b).
The speed (or rate) of a transition t is called intensity, it is denoted
λ[t] and it represents the number of times t occurs per time unit.
The default intensity of t is denoted λ0[t], which is a default speed
that can be increased or decreased by the “intensity net”. The
default intensity of a transition t, λ0[t], can be written inside t, for
instance the default intensity of R1 is λ0[R1] = 3. Similarly to the
initial marking in an “event net”, uncertain default intensities can
be incorporated by means of inequalities, e.g., 3.9≤ λ0[R2]≤ 4.1
would mean that the default intensity of R2 is uncertain but within
the interval [3.9,4.1]. Notice that if the speed of a transition t can
be manipulated by an external controller, then λ0[t] can be
interpreted as a control action that is applied to the system.
As in an event net, the key element of an intensity net is an
“intensity handler”, which is depicted as a dot (see s1 and s2 in Fig.
1b). Places and transitions are connected to intensity handlers by
edges and arcs respectively. A place connected to an intensity
handler means that the tokens in that place are able to modify the
speed of the transitions connected to the handler; an arc to/from
the transitions implies that the speed will be increased/decreased
by such tokens. Thus, in contrast to event nets, the tokens are
neither consumed nor produced in the intensity net, just used to
modulate the speed of transitions.
The speed of the transitions is determined by the set of
inequalities associated with the intensity handlers. For instance,
the intensity handler s1 in Fig. 1b is connected to place X (for
instance, an enzyme) and transition R1; this means that the rate of
R1 depends on the marking of X. The labels r and x of the arc and
edge connected to s1 denote the increase of intensity in R1
produced by s1, and the number of tokens of X used by s1 to
produce intensity in R1 respectively. If the equation r = 2x is
associated with s1 then each token in X used by the intensity
handler increases the rate of R1, which by default is λ0[R1] = 3, by
two units. As an example, assume that the marking of X is 4, i.e., m
[X] = 4, then the rate of R1 is λ[R1] = λ0[R1] + 2m[X] = 11 if s1 uses all
the tokens in X to produce intensity in R1. Uncertain reaction rates
can be modeled by inequalities, e.g., the inequalities 1.9x≤ r≤
2.1x associated with s1 mean that each token increases the speed
of R1 in a nondeterministic amount in the interval [1.9,2.1]. The
fact that the speed of a reaction might depend on the coordinated
activity of several molecules can be modeled by connecting
several places to an intensity handler. Assume that the equations
Fig.1 Constitutive elements of an FN and FN example. a Handlers provide a “ﬂexible” layer between places and transitions. In the event net,
places are connected to event handlers through arcs, and transitions are connected to event handlers through edges. In the intensity net,
transitions are connected to intensity handlers through arcs, and places are connected to intensity handlers through edges. b FN modeling a
system with two reactions, R1: A→ B and R2: C→ D + E, that are regulated by the molecules X (e.g., an enzyme) and Y (e.g., an activator). An FN
consists of an event net (green elements) and an intensity net (blue elements) that share places and transitions. While the event net models
how the reactions determine the changes in the state, the intensity net models how the state determines the rates of the reactions. The
potential evolutions of the FN depend on the inequalities associated with handlers
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r = x = 0.5y are associated with s2. That would imply that one token
in Xmust be associated with two tokens in Y (Ymight represent an
enzyme activator) to increase the speed of R2 by one unit. Note
that a token in A can be used either to modulate the speed of R1
or R2, such a choice is nondeterministic.
The intensity nets in Fig. 2c–f show some of the basic modeling
capabilities provided by the intensity handlers such as synchro-
nization, choice, uncertainty handling, and interplay between
positive and negative modulators. Notice that the nets in Fig. 2
can be seen as basic building blocks with which to construct larger
and more complex nets.
Flexible nets (FNs)
The combination of an event net and an intensity net results in an
FN (see Fig. 1b). In an FN, the event net determines the way
intensities produce marking changes, while the intensity net
determines the way tokens produce intensity changes. Notice that
FNs represent an abstract modeling formalism not necessarily
constrained to biological systems. In fact, the FN in Fig. 1b admits
interpretations from other application areas. For instance, from a
manufacturing perspective R1 and R2 could model actions
performed on two assembly lines, one line starting at A and the
other at C. From this point of view, X could be a shared resource,
e.g., a robot, required by both lines and Y a resource just required
by one assembly line. From a computing point of view, A and C
could be seen as data streams that need to be processed by server
X, and by server X in cooperation with server Y, respectively.
Given that an FN can accommodate uncertain parameters, there
is no unique possible trajectory for a modeled system, but a
number of possible trajectories arising from the inequalities
associated with initial markings, default intensities, event and
Fig. 2 Event net examples (a and b) and intensity net examples (c, d, e and f). a Let us assume that the stoichiometry of a given reaction R is
not completely known and can be expressed as R: nA + 2nB → C where n is known to be between 10 and 12. That is, the production of one
molecule of type C requires a quantity of molecules of type A that is in [10,12] and twice as many molecules of type B. Such a reaction can be
modeled by the event net in A together with the set of inequalities 10r≤ a≤ 12r; b= 2a; c= r associated with event handler v1. R can be
expressed as R:nA + 2nB→ C where n is known to be in [10,12]. The inequalities in v1 are interpreted as follows: If one reaction occurs, then r =
1 and one action in R is used to change the marking in places. In order to satisfy the inequalities, a, which is the number of tokens consumed
from A, is between 10 and 12 (the actual value of a is chosen in a non-deterministic way for each occurrence of R), b, which is the number of
tokens consumed from B, is b= 2a, and c, which is the number of tokens produced in C, is c= r= 1. Assume that the initial marking of places is
m0[A]= 20, m0[B]= 22, m0[C]= 0. The occurrence of R drives the system non-deterministically either to m[A]= 10, m[B]= 2, m[C]= 1, or to m[A]
= 9, m[B]= 0, m[C]= 1. Notice that, for this initial marking, a cannot take a value higher than 11 as it would lead to a negative m[B]. The
consumption and production of tokens is instantaneous and coincident. b Net modeling a reaction R with two alternative set of reactants and
products, the set of equalities associated with the event handlers are v1:a= p= b= r, v2:c= p= d= r; either A and P are reactants and B is
product, or C and P are reactants and D is product. In a chemical context, this net might model a reaction R that either takes A and P as
reactants and B as product, or C and P as reactants and D as product, i.e., R is either A + P→ B or C + P→ D. In the ﬁrst case, the occurrence of
the reaction, i.e., the action in R, is implemented by the edge connected to v1, and in the second case by the edge connected to v2. The
selection of the event handler that uses the action is done non-deterministically for every occurrence of the reaction. This net can be
interpreted in different ways: (a) The transition could model an event that can be observed, and whose occurrence can produce different
marking changes which are modeled by the event handlers. For instance, the transition can model a biochemical event such as
phosphorylation, but it is not possible for the observer to determine whether molecule A or C has been phosphorylated. (b) The transition
could model an input action whose effect on the system is not fully controllable as any of the connected event handlers can make use of the
reaction. c Net establishing a synchronization between the tokens in A and the tokens in B by means of the equation s1:2a= b= 2r associated
with s1. More precisely, when a token in A synchronizes with two tokens of B, the intensity in transition R is increased by one unit. d Let s1:a=
r1= r2, then a token in A produces simultaneously an intensity unit both in R1 and R2, i.e., it can be informally said that the intensities of R1 and
R2 are synchronized by the tokens in A. e Let s1:a= b= r and s2:c= d= r, then a token in A together with a token in B produce an increase of
one unit in the intensity of R. Similarly, a token in C together with a token in D produce a decrease of one unit in the intensity of R. Thus, the
tokens in A and B can be seen as positive modulators and the tokens in C and D as negative modulators. f Let s1:10a≤ r≤ 12a and s2:a= b= r.
The net models a choice in place A, i.e., a token in A can be used either to produce an intensity within the interval [10,12] in R1 or, together
with a token in B, an intensity in R2 of one unit. The choice of the intensity handler that uses the tokens in A is non-deterministic; in contrast to
the actions used by event handlers, it can change over time. In other words, a given token in A can modulate the intensity in R1 during a given
time period and then synchronize with a token in B to modulate intensity in R2
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intensity handlers. In order to account for all these possible
trajectories, a set of linear and quadratic constraints has been
developed (see S1). The values that satisfy these constraints are
the possible states that the system can reach. In order to compute
a state that maximizes a given property, an objective function can
be added to these constraints; this results in a programming
problem that can be solved by state-of-the-art solvers.20,21 Among
the existing control possibilities, FNs are especially well suited for
model predictive control.22 Under model predictive control, a
number of time intervals (or sample times) are considered, and the
programming problem described above yields the state of the FN,
as well as the control action λ0, for each time interval. Such a
control action is implemented during the ﬁrst interval only, at the
end of the ﬁrst interval the state of the system is updated and the
procedure is repeated. See S1 for the model predictive control
approach in FNs.
The FN in Fig. 3a models an exponential decay, e.g., the
degradation of a molecule (the marking m[A] would be the
number of molecules), with uncertain rate. Figure 3b shows two
potential time trajectories of the FN, low(m[A]) and up(m[A]), that
have been obtained by means of the mentioned programming
problem. More precisely, once the linear and quadratic constraints
are established, low(m[A])/up(m[A]) is obtained by an objective
function that minimizes/maximizes m[A]. In this way, low(m[A])
and up(m[A]) are lower and upper bound trajectories that
encompass all the possible time trajectories arising from the
uncertain rate.
Guarded FNs
Intensity nets can model intensity uncertainties by means of the
linear inequalities associated with the intensity handlers. Although
Fig. 3 FN and guarded FN examples. a FN modeling an exponential decay with uncertain rate. Let v:a= r and s:0.9a≤ r≤ 1.1a, then the FN
models the exponential decay of a molecule of type A whose exact rate is uncertain but known to be in the interval [0.9[A],1.1[A]], where [A] is
the concentration of A. b Evolution of two objective functions with m0[A]= 5 and λ0[R]= 0. The dashed and the solid lines correspond to the
maximization and the minimization of m[A], respectively. The trajectories provide an upper and a lower bound for the potential evolutions of
m[A]. The plot has been obtained by model predictive control with sample time of 0.1 units and a prediction horizon of one step. c Guarded
FN modeling an activation process. Let v1:a= r, v2:b= r, s1:a= r and s2:r= 0 if m[A]>1, s2:r= 1 otherwise. Notice that the equations associated
with s2 depend on the state, more precisely on m[A]. Moreover, note that the tokens in A are not used to produce intensity in R2, and hence A
is not connected to s2. The net models an exponential decay of molecule A, and a constant production rate of molecule B of 0.1 (this is
modeled by λ0[R2]= 0.1) when m[A]>1 and of 1.1 when m[A]≤ 1. Thus, A can be seen as a repressor that only allows a residual production of B
when m[A] is higher than 1. There are only two regions in this net, one is deﬁned as m[A]>1, the other as m[A]≤ 1. d Marking evolution with
m0[A]= 5, m0[B]= 0, λ0[R1] = 0, λ0[R2]= 0.1, and the objective function is to minimize m[B]. It can be seen that the linear growth of m[B]
changes from rate 0.1 to 1.1 when m[A] falls below 1. The plot has been obtained through model predictive control with a sample time of 0.1
and a prediction horizon of one step
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such linear inequalities can also be used to approximate non-
linear dynamics, the resulting accuracy may not be satisfactory. In
order to better approximate non-negative dynamics, guarded FNs
are proposed.
In a guarded net, the set of potentially reachable markings is
partitioned into a set of regions. Each region deﬁnes an “operation
mode”, and intensity handlers are associated with a set of linear
inequalities per region. The set of linear inequalities determining
how intensities are produced is the one associated with the region
where the marking lies. See Fig. 3c, d for a guarded net modeling
the activation of production of molecule B when m[A] is below 1.
In order to account for guarded FNs, the programming
problems developed for FNs were extended and the addition of
binary variables was required. For the sake of simplicity, both FNs
and guarded FNs will be referred to as FNs in what follows. Formal
deﬁnitions of FNs and methods to analyze them through
programming problems are provided in S1. We have developed
a new software tool called fnyzer (see Code in SI) that implements
these methods.
Validation of the FN methodology: dynamics of glucose
consumption by yeast population
As a proof-of-concept study, we modeled the uptake and
consumption of glucose by yeast cells leading to cell duplication
and consequent growth of the population. We mathematically
described how these dynamic events are coordinated by different
hexose transporters and glucose sensors as the availability of
glucose varies over the course of time. We then studied situations
in which we introduced perturbations to an ideal system and we
describe control actions to overcome these perturbations so that
the population could cope with changes in the physiological
parameters, or with spontaneous mutations in the cells during
cultivation. Although novel features, such as the modeling of the
hierarchical coordination of dynamic metabolic events or the
identiﬁcation of control actions that need to be taken to meet
given criteri,a can only be exploited by the FN methodology, we
bench-marked our results against a parallel analysis that used
ODEs whenever possible.
We tracked the fate of an average individual cell from its
inoculation into a glucose-rich batch culture and followed the
trajectory of its uptake of glucose, growth, and its cell division
until the carbon source available per average cell became scarce
due to both consumption and the increase in the size of the
population. In order to simulate a complete batch growth proﬁle,
we considered seven replication periods of 105min each. We
illustrate the approach as a black-box cell system where the
glucose was transported and used for growth and maintenance.
Figure 4a sketches the glucose ﬂows in the modeled system (see
S2 for details on the FN modeling the system and its parameters).
The amount of extracellular glucose (Go) can be increased by
means of an inﬂow (F) that represents a control action that can be
applied into the system in order to control it. The model includes
two sensors (Rgt2p and Snf3p) and nine tranporters (Hxt1p-7p,
Fig. 4 Main ﬂows of the glucose consumption and Wilson disease models. a Sketch of the ﬂows in the glucose consumption model. The
model captures the amount of extracellular (left) and intracellular (right) glucose. An inﬂow (F) of glucose can be fed into the system, this ﬂow
will be determined by the solution of control methods. The extracellular glucose is sensed and transported into the cell, where it is utilized. b
Sketch of the main ﬂows in the Wilson disease model. The copper intake ﬂow is initially split in two. One of the ﬂows, accounting for at most
1% of the intake33 undergoes oxidation resulting in the production of hydroxyl radicals. These radicals can be neutralized by antioxidants.
After oxidation, copper is excreted in the urine via the kidneys. The remainder of the intake ﬂow, accounting for at least 99% of the intake, is
split in two further ﬂows. One of them is used to fulﬁll the body’s copper requirements, which are around 0.9 mg/day.31 The copper excess is
not used and is removed through the feces. If ATP7b is non-functional, this impedes the normal excretion of the excess copper into the bile
ducts and, as a result, some of it is oxidized, producing more hydroxyl radicals
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Hxt13p and Hxt17p). Each sensor and each transporter has an
afﬁnity proﬁle based on Go. If at least one sensor and one
transporter is active for the current amount of Go, then the
transport rate is positive (see S2 for the rate equation), otherwise
the transport rate becomes 0. The utilization rate of intracellular
glucose (Gi) was set to 199e-6 mM/min to meet the glucose-
equivalent energy required for maintenance23 normalized for a
single yeast cell.
Three possible situations for the glucose consumption system
were assessed. We ﬁrst investigated how the wild-type yeast cell
transported glucose across its membrane and utilized it for
growth and maintenance. A cell division was assumed to take
place at the end of each doubling period, approximated by the
accumulation of intracellular glucose to double its initial content.
Only half of the remaining amount of extracellular glucose was
available for a single cell after each division.
The trajectories we obtained using the FN model for the
evolution of intracellular and extracellular glucose concentrations
as the latter become depleted were observed to follow a similar
path to the trajectories obtained by the ODE models. This
validated the operating principles of the methodology and were
also congruent with empirical physiological observations on yeast
cells (Fig. 5a–d).24 These trajectories were obtained by model
predictive control22 with a sample time of 1.0 min and a prediction
horizon of one step (according to this control approach, the
programming problem derived from the FN model is optimized at
each sample time, and the obtained solutions represent the values
of the state variables that optimize the given objective function). A
shift in intracellular dynamics was observed as the availability of
extracellular glucose changed over time. The remarkable increase
we observed in the rate of glucose uptake and its intracellular
concentration upon depletion of the external resources was in line
with earlier reports.25 The FN upper-bound and lower-bound
trajectories for [Gi] and [Go] were shown to enclose the ODE
trajectory throughout the time frame of analysis. The maximum
deviation from the ODE prediction remained within 12%
throughout the low-afﬁnity regions (Fig. 5a, b) whereas the
maximum deviation was as high has 95% in the high-afﬁnity
regions (Fig. 5a). Tighter bounds with the maximum deviation
remaining within 17% were achieved with a shorter sample time
C
F
A
G H I
D
B
E
Fig. 5 Analysis of the glucose consumption system by FNs. a Evolution of intracellular glucose for a wild type yeast cell conﬁguration
throughout the cultivation time. b A close-up trajectory for [Gi] during the initial 3 replication events. c Tighter upper and lower bounds
achieved during the transition from the low-afﬁnity to high-afﬁnity regions by lowering the sample time to 0.1 min. In a–c, the blue solid line,
blue dashed line, and the green solid line represent the lower bound, upper bound, and the ODE trajectories for [Gi], respectively. d Evolution
of extracellular glucose for the wild type cell population throughout cultivation. The black solid line, black dashed line, and the magenta solid
line represent the lower bound, upper bound, and the ODE trajectories for [Go], respectively. e Control action, λ0[F], to maintain a steady
supply of [Go] at 110mM. f Control action, λ0[F], taken to overcome the effect of hxt4Δhxt13Δhxt17Δ triple deletion on the cultivation. The
control action was required at t= 420min to keep [Gi]>1e-6 mM and minimize the amount of glucose introduced to the system. The obtained
control law imposes an impulse of glucose F to return the system to a state with a non-zero transport rate. Similar impulses are required for
subsequent cell divisions. In e–f, the black, blue and red solid lines represent the trajectories of m[Go], m[Gi], and λ0[F], respectively. g Upper-
bound and lower-bound trajectories of [Gi] with uncertain utilization rate in the interval [198.9e-6,199.1e-6] mM/min. h Upper-bound and
lower-bound bound trajectories of [Gi] with uncertain utilization rate in the interval [198.0e-6,200.0e-6] mM/min. In g–h, the solid and dashed
lines correspond to the lower and upper bound trajectories of [Gi]. i Trajectories of [Gi] predicted by the ODE model with exact utilizaton rates
of 199.4e-6 mM/min and 199.3e-6 mM/min. In i, the solid line corresponds to a utilization rate of 199.4e-6 mM/min, and the dashed line to a
utilization rate of 199.3e-6 mM/min
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of 0.1 min (zoomed in section in Fig. 5c) in the non-ﬂat, high-
afﬁnity region of the graph. The maximum deviation between the
upper-bound and lower-bound trajectories and the ODE trajectory
for [Go] remained negligible throughout the time course of
analysis (Fig. 5d). The substantial difference in the number of
glucose molecules available in the cell as compared to that
outside was the main reason for the differences observed in the
deviation trends for [Gi] and [Go]. Lowering the sampling time
provided an immediate solution to overcome this challenge.
Having bench-marked the formalism, we then exploited this
system and demonstrated how FNs can be used to handle two
very different control problems in biology. The ﬁrst control
problem focused on maintaining the physiological state of a
microbial fermentation. The control goal was to compute the time
trajectory of λ0[F], so that [Go] is maximized and constrained to
[Go]≤ 110mM. The control action λ0[F] was obtained by optimiz-
ing a programming problem that had “max [Go]” as the objective
function and was subject to the constraints associated with the FN
model plus [Go]≤ 110mM. In this programming problem, λ0[F]
was taken as a variable and the actual value of λ0[F] obtained by
the optimization was the control action to be implemented in the
system. The overall time trajectory of λ0[F] was obtained by a
model predictive control approach, according to which the
mentioned programming problem was solved at each sample
time, and the control action was applied at each of the sample
times. The computed trajectory suggested that a reasonably low
and nearly constant supply of glucose (199e-6 mM/min) was
required throughout the cultivation with impulses of glucose
provided at the time of cell division (Fig. 5e).
As the second control problem, we studied the question of how
to overcome the physiological problems arising in a microbial
fermentation as a consequence of a genetic modiﬁcation of the
yeast. A deleterious genetic change (hxt4Δhxt13Δhxt17Δ) was
considered in this situation. While this is a very extreme case that
would never occur by spontaneous mutation, it presented a
suitably tough challenge to use to test the control capabilities of
FNs. The goal was to maintain the cell in a physiological state
where these medium-afﬁnity transporters (see S2) would not be
required for survival or for growth, while the fermentation was still
economically feasible. The control goal was to keep [Gi] ≥ 1e-6
mM and to minimize the amount of glucose put into the system.
The control trajectory was obtained through the approach
described in the previous control problem. No control action
was required when the cultivation proceeded with the relevant
transporters in action and [Gi] was above the set threshold. The
cell division event at 420min moved [Go] to a region where the
system could not operate due to the absence of the relevant
transporters (see region low_A in S2). The control law that was
invoked to counteract the cessation of glucose uptake, which
would in time lead to the depletion of [Gi], dictated the impulse-
like supplementation of glucose (λ0[F]) to bring the system back to
the region low_B (see S2). Similar impulses of glucose were
required for the subsequent division events (Fig. 5f).
As a ﬁnal validation exercise, we investigated the responsive-
ness of the system to the rate at which glucose is consumed for
maintenance purposes. In order for the model to correctly
represent yeast physiology, we expect the glucose-equivalent
maintenance requirement, which is independent of the speciﬁc
growth rate, and consequently of the availability of nutrient and
energy resources ([Go]), by deﬁnition, to remain unchanged. Since
the maintenance portion should represent the minimal survival
requirement for the cell, the model was expected to be highly
sensitive to even very small reductions in this value.26 To test this
notion, we ran several simulations varying the rates of main-
tenance and monitored how [Gi] was affected during replication
events. Conﬁrming our predictions, the model only tolerated
±0.05% deviation from the empirical value (Fig. 5g) to maintain
“survival”, and [Gi] was observed to be rapidly depleted within a
single replication event, indicating inviability in the model even
when this range was extended to ±0.5% (Fig. 5h). We then
identiﬁed the break-even conﬁdence interval for the maintenance
requirement as ±0.15% as predicted by the ODE model (Fig. 5i).
The modeling and control of single-cell behavior, such as the
problem discussed above, is of particular interest when imple-
menting design and control strategies for microﬂuidic cell culture
systems such as “lab-on-a-chip” devices. FNs can also be readily
exploited to model and control systems of populations of
asynchronously dividing cells, e.g., a population of cells in a
fermenter at either the laboratory or industrial scale.
Modeling of copper accumulation in Wilson disease and its
treatment
Rare medical disorders present challenges that are associated with
both the data and the available analytical tools. The low rate of
incidence of such diseases hinders the collection of extensive data
on both patients and disease mechanisms. The impracticability of
gathering large patient cohorts makes it difﬁcult or impossible to
conduct extensive drug trials. The limited size of the target group
is often a ﬁnancial discouragement to the development of new
treatments. All of this means that rare or neglected diseases are
very likely to beneﬁt from the application of model-based
approaches, to accelerate both clinical and non-clinical research,
since they can substantially reduce the time and costs associated
with an in-depth investigation of a condition or the evaluation of
alternative treatment strategies, shortening the path to success.27
Wilson disease is an autosomal recessive heritable disorder
affecting an individual’s copper metabolism. The copper taken in
with the diet and stored by the hepatocytes in the liver is
transferred to a carrier protein called apoceruloplasmin (ACP) to
form a six-copper binding protein known as ceruloplasmin (CP).
CP is then released into the bloodstream, and is the source of
copper for organs such as the brain and kidneys; any excess
copper is excreted into the bile ducts. Both of these key functions
in copper metabolism are mediated by the copper-transporting P-
type ATPase; ATP7b.28,29 Mutations in the gene encoding ATP7b
can result in the accumulation of copper deposits in the body
leading to Wilson disease.
The disease is very rare and presents a multisystemic
symptomatology with non-speciﬁc neurological, hepatic, psychia-
tric, or osseo-muscular manifestations (Orphanet; citing informa-
tion at ref. 30). Although some progress in understanding disease
mechanisms and treatment strategies has been made, a number
of issues regarding its treatment remain open. Generally, the
course of treatment involves reduction in the dietary intake of
copper; inhibition of copper absorption; stimulation of the release
of accumulated copper in various tissues; alleviation and, if
possible, reversal of any possible organ and tissue damage
observed at diagnosis. A lifelong regime of maintenance therapy
is then prescribed to prevent the reaccumulation of copper. An
alternative treatment regime, involving the use of antioxidants in
the treatment has been reported in some studies and has been
claimed to sometimes result in symptomatic improvement.31
Furthermore, although the extent of accumulation of copper in
the liver is generally accepted as a clinical diagnostic measure,
follow-up liver biopsies to monitor whether treatment results in
reduced copper levels are not commonly performed. Instead, the
progress of the treatment is usually monitored by taking blood
samples and measuring 24-h urinary copper excretion rates. We
set out to compare the likely efﬁcacy of the different treatments
by exploiting FN modeling.
The disease begins with liver dysfunction, with patients affected
in their early years being likely to be affected by liver damage.32
whilst older victims tend to present with neurological symptoms.
Therefore, we chose to model the hepatocytes, where the disease
ﬁrst manifests itself. We deﬁned the model boundaries
Wilson disease
J Júlvez et al.
8
npj Systems Biology and Applications (2018)  7 Published in partnership with the Systems Biology Institute
considering the liver as the system. First, we allowed the model to
select a value for the daily intake of copper that is within the range
recommended by the WHO; this value then determines the inﬂux
of copper to the system (CI). We allow 99% of this amount to be
processed through the control of ATP7b. The copper required to
be released into the bloodstream to be transported to different
parts of the body, such as the brain and the kidneys, is transferred
(at rate CR) onto ACPs and the holoceruloplasmins are then
released into the bloodstream. Excess copper is guided to the
biliary ducts (CFBD) in a process that is also under the control of
ATP7b. One percent of the copper remains unbound and is readily
oxidized in the presence of H2O2. The copper is then discharged
from the liver and discarded by urinary excretion (CFUE). This
oxidation reaction generates hydroxyl radicals that are neutralized
by glutathione, the natural antioxidant found in the liver. A
schematic representation of this model is provided in Fig. 4b (a
detailed description of the FN model and its parameters can be
found in the S3). The model parameters depend on the “case” or
“state” under consideration. Here, we have considered four
different states: healthy (no copper accumulation), sick (copper
accumulation dependent on ATP7b functionality), copper absorp-
tion blocking treatment, and urinary excretion induction
treatment.
In order to construct our model, we ﬁrst used medical practice
guidelines to constrain the system to represent the fully functional
copper metabolism of healthy individuals. We identiﬁed the
maximum average daily copper intake as 1.98 mg in order to
avoid any accumulation of copper in the liver. We carried the
analysis out for a period of 70 years to monitor how the system
evolved throughout a realistic lifespan. The upper bound of the
range we explored denoted the maximum tolerable limit for
copper ingestion without causing toxicity (10 mg/day); therefore,
the fact that the model predicted the maintenance of a healthy
hepatic copper balance only when the average copper intake in
the diet was considerably lower than this maximum tolerable limit
is consistent with reported dietary guidelines. However, we should
also note that this value represents the daily amount of copper
that would be available in the hepatocytes for further processing.
It assumes that the absorption of copper from the intestines, and
its conveyance via Cmt1 and Atp7a into the system boundaries
(which were not investigated within the scope of this analysis),
were carried out with 100% efﬁciency. This source of under-
estimation should be taken into consideration in evaluating the
model predictions.
We also investigated the fate of hepatic copper for various daily
copper intakes that were representative of different diets. We
determined the maximum and minimum level of accumulated
copper that could be caused by these different diets (Fig. 6a).
Maximizing the rate of the accumulation of copper in the liver
rapidly caused an excess accumulation of the metal, irrespective
of the copper intake value chosen within the deﬁned range
However, since living systems operate to maintain a steady state
as long as possible, it is not unlikely that the cellular objectives
coincided with the minimization of the hepatic accumulation of
A B
C D
Fig. 6 Copper accumulations predicted by the FN model (a–b) and performance of two treatments (c-d). a Maximum and minimum level of
copper accumulations for different daily intakes. Red/green/blue lines refer to daily copper intakes of 2.0/2.2/2.4 mg. Maximum/minimum
accumulations are represented with dotted/solid lines. The minimum accumulations for 2.0 mg/day and 2.2 mg/day copper intakes are
constant and have the same proﬁle. The black line at 1850mg represents the diagnostic threshold. b Minimum copper accumulations for
different levels of ATP7b enzyme activity. The cyan/red/green/blue lines correspond to 7%/23.1%/39.3%/55.5% of wild-type activity. The black
line at 1850mg represents the diagnostic threshold. c–d Proﬁles of the accumulation of copper during treatments to either block its
absorption or induce its excretion (also known as cuprupria induction), with initial copper concentrations of 1850mg in C and 7400mg in D.
The black line represents a normal copper level in a healthy individual
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copper in this in silico analysis. The hepatic accumulation was not
completely unavoidable even when the intake rate was mini-
mized. However, for a daily intake of 2.23 mg of copper into the
liver, the accumulation throughout life was not so high as to
exceed the limits provided in the medical guidelines for disease
diagnosis (1850 mg equivalent to ≥ 250 μg/g dry weight).
The model was then used to investigate Wilson disease with
various degrees of loss of ATP7b enzyme activity (Fig. 6b). We
constrained the model to minimize the accumulation of copper in
the liver since the robustness of the living system will act to
minimize the effect of ATP7b dysfunction. We observed that
proportional activities (compared to wild type) above 0.7 did not
cause any accumulation of copper in the liver with the given
constraints and the adopted objective. This was in line with earlier
reports on the genotype–phenotype relationships in Wilson
disease investigating the loss of ATP7b activity in mutants having
both a pathogenic or a neutral phenotype where any mutant with
a loss in enzyme activity less than 30% maintained normal copper
transport capability33 and thus was considered neutral in its
phenotypic effect. We investigated a relatively severe case of a
44% loss in ATP7b activity and determined that the hepatic
copper accumulation exceeds the diagnostic limit of 1850mg at
the age of 28 (Fig. 6b). The model successfully predicted cases,
where as much as 93% of the activity of the adenosine
triphosphatase 7 was lost, leading to sufﬁciently high hepatic
copper accumulation to allow deﬁnitive diagnosis within the ﬁrst
year of life (blue line in Fig. 6b). Any further loss in enzyme activity
did not yield feasible predictions within the constraints used in the
model, although human mutants leading to even higher losses in
enzyme activity have been reported.33 However, cases with
extremely early onset of the disease34,35 caused by mutations
leading to a severe loss of ATP7b did not always present in a
manner that complied with the constraints we had imposed on
system, based on the published practitioners’ guidelines.31 Such
an example was observed for the case of a 9-month-old patient
with no change in urinary copper concentration despite a high
hepatic copper accumulation (ca. 5550mg) and high free serum
copper concentration.35 The inability of the constrained model to
account for these extreme cases may indicate the existence of as
yet undiscovered mechanisms involved in the very early onset of
the disease.
Having established the “sick” states in silico, we then
investigated two alternative treatment strategies. The ﬁrst involves
blocking the intestinal absorption of copper and limiting the
copper available for transport into the liver. This strategy will be
referred as “copper absorption blocking”. Since normal bodily
functions still demand a ﬁxed amount of copper, insufﬁcient
uptake of copper creates a copper deﬁcit that the body meets by
calling on the copper accumulated in the liver, thus gradually
relieving the diseased condition. The other treatment strategy
involves the drug-induced release of hepatic copper stores by
directing copper towards urinary excretion. This second strategy
will be called “urinary excretion induction", or "cupruria-inducing
treatment”. Both these routes are employed in the clinic in a two-
stage therapeutic regime. The ﬁrst stage is the acute or
symptomatic treatment that aims at depleting the accumulated
copper; the second stage is the "maintenance" treatment that
consists of a 25% reduction in treatment dosages for lifelong
maintenance therapy.
We focused on the severe loss of 93% of ATP7b enzyme activity
and investigated the effect of early detection on the progress of
both treatments, and how the length of the acute treatment
varied in the two treatment regimes. The model was used to
predict the copper depletion proﬁles from two different initial
levels of copper accumulation: (a) the lower diagnostic limit for
hepatic copper accumulation adopted in liver biopsies (1850 mg)
(Fig. 6c) and (b) four times this lower limit as the upper bound
(7400mg) (Fig. 6d) to account for diagnosis at a much later
stage.36 We monitored the depletion of the hepatic copper stores
during treatment as a measure of recovery. We found that,
although the two treatment strategies have different mechanisms
of action, the time of response to either treatment was predicted
to be similar. For a model of the hepatic copper accumulation of
1850 and 7400mg at the time of diagnosis, the absorption
blocking treatment could deplete copper stores in 1335 days and
5470 days, respectively; whereas these values were determined as
1450 days and 5744 days in the case of modeling cuprupria-
inducing treatment.
We also computed the maximum allowable copper intake
during the maintenance treatment in order to ensure that hepatic
copper levels remain within healthy bounds. For the absorption
blocking treatment, this maximum intake computed by the FN
model was 1.34 mg/day, and for the urinary excretion induction
treatment 1.67 mg/day.
The accumulation of copper was reported to trigger inﬂamma-
tion in the liver since the copper readily oxidizes generating
hydroxyl radicals.37 As a ﬁnal query, we investigated the potential
for using exogenous antioxidant supplements to relieve such
inﬂammation. Supplementation of the diet with alpha-tocopherol
(vitamin E) has been suggested as a possible route to provide
symptomatic improvement for individuals suffering from Wilson
disease.31 Our results indicated that the endogenous supply of
glutathione was sufﬁcient to address the burden of hydroxyl
radicals formed by the oxidation of the copper accumulating in
the liver. This suggests dietary supplementation with antioxidants
is unlikely to provide any additional beneﬁts to the established
two-phase therapy.
DISCUSSION
We have developed and implemented FNs, as a formal framework
for the modeling, analysis, and control of complex dynamic
systems. FNs were inspired by Petri nets and are useful for
intuitively modeling the relationships between the state of the
system and the processes altering it. FNs are able to approximate
non-linear dynamics, and handle uncertain parameters without
relying on statistical methods. This framework should be especially
valuable to meet the modeling demands of biological systems and
to overcome the challenges associated with the use of the
available biological data. The strength of the FN approach, as
demonstrated by the design and control of the model of glucose
consumption, lies in its ability to incorporate highly heteroge-
neous and imprecise data but, nevertheless, provide predictive
models of biological systems and predictive control of biopro-
cesses. FNs thus ﬁll gaps in the utility of existing formalisms and
provide an important new tool that may be exploited by both
research scientists and bioprocess engineers.
In this paper, we have demonstrated that predictive mathema-
tical models constructed and analyzed using the FN formalism,
which has been speciﬁcally designed to meet the demands of
biological systems, can make a signiﬁcant contribution to our
understanding, especially when only limited information on the
system is available. FNs have allowed us to integrate and exploit
uncertain biological data by providing a uniﬁed formal model that
is suitable for mathematical analysis. In particular, FNs have
proven their usefulness in the investigation of the physiological
changes that occur in patients suffering from, or being treated for,
Wilson disease. We determined that the body’s endogenous
antioxidant supplies were sufﬁcient to meet the production of
additional hydroxyl radicals caused by the accumulation of copper
in the liver. This allowed us to conclude that the inﬂammation in
the liver cannot be entirely due to the formation of hydroxyl
radicals and that other, indirect routes must be involved in the
induction of oxidative stress. Furthermore, we identiﬁed the
trajectory for how the level of copper accumulated in the liver
could be reduced by treatment. This model can correctly suggest
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a projection of how the treatment will alter the copper content of
the liver, without having to resort to invasive methods.
METHODS
The inequalities associated with the handlers make the evolution of FNs
non-deterministic (note that deterministic behaviors can also be modeled
with appropriate inequalities). In order to cope with such non-determin-
ism, a set of mathematical approaches that constrain the potential
markings that the net can reach has been developed. Namely, approaches
to constrain the following set of markings are available: a) markings that
are reachable just using the event net (this ignores the intensity net and
corresponds to an untimed interpretation); b) markings that are reachable
after τ time units, where τ is a positive real number (this corresponds to a
transient state analysis).
The obtained constraints represent necessary conditions for reachability.
The tightness of the constraints depends on the net structure and on τ for
transient analyses (generally the lower the value of τ, the tighter the
constraints). In order to obtain a trajectory of the marking over time,
intermediate sampling instants (not necessarily evenly distributed) can be
introduced. At each sampling time, the marking is a variable within a
bounded set and time-dependent parameters can be modeled. This
usually involves using a high number of inequalities to deﬁne the
constraints. To alleviate this complexity, model predictive control22
approaches have been implemented. Such approaches can deal with
sample times of different lengths and can reset the marking when a given
condition is satisﬁed.
Once the constraints of an FN are obtained, objective functions of
interest can be deﬁned to analyze the system. This results in an
optimization problem whose solution represents a bound for all the
potential system behaviors (see S1 for details). In FNs, both the initial
marking,m0, and the default intensities, λ0, can be taken as variables whose
values must satisfy given sets of linear inequalities. In this way, m0 and λ0
become variables of the problem to be optimized. Once the problem is
solved, the values assigned to m0 and λ0 can be implemented in the real
system to optimize the deﬁned objective function. Thus, both analysis and
control are carried out in a similar way in FNs, the only difference being that
m0 and λ0 are taken as control variables when control is considered.
The net models, together with the analysis and control methods, have
been implemented in Python 2.7 (https://www.python.org). The software
makes use of Pyomo38,39 to build the optimization problems and Gurobi21
and CPLEX20 to solve them.
The performance of FNs remained within reasonable limits of CPU time
(Intel i7, 2.00 GHz, 8 GiB, Ubuntu 14.04 LTS). Namely, the CPU time to
compute one step in the glucose consumption model was 5.96 s for the
wild-type cell and 44.36 s for the mutant with the state space partitioned in
four and ten regions, respectively. With respect to the Wilson disease
model, the proﬁles were obtained by optimizing the transient state of the
FN over: (a) 10 steps of 7 years for the healthy and sick states (CPU time:
12.14 s); (b) 12 steps of 4 months for the acute treatments starting at a
hepatic copper content of 1850mg (CPU time: 34.47 s); (c) 24 steps of
9 months for the acute treatments starting at a hepatic copper content of
7400mg (CPU time: 98.04 s); and (d) 4 steps 5 years for the maintenance
treatments (CPU time: 4.44 s). The dense sampling in the acute treatments
allowed us to reveal the slight differences in their proﬁles (Fig. 6c, d).
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